ArticlePhysiological reports2026
Testosterone status and bone mineral density in Finnish male endurance athletes: Baseline associations and 1-year follow-up.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study examined whether low-normal serum total testosterone (T) is associated with bone mineral density (BMD) or bone stress injuries (BSI) in male endurance athletes. Baseline data from 46 national- to international-level Finnish athletes (age 24.8 ± 3.6 years; biathlon, cross-country skiing, orienteering, triathlon, Nordic combined, endurance running) were analyzed; 31 completed 1-year follow-up. Participants were categorized into low T (lowest quartile: 11.8 ± 1.8 nmol/L) and normal T groups (17.9 ± 3.1 nmol/L; p < 0.001). At baseline, BMD and Z-scores did not differ at any site (all p > 0.5), and BSI history prevalence was similar in low T (41.7%) and normal T groups (29.4%). The low T group had lower IGF-1 (p = 0.031) but comparable cortisol and insulin. During follow-up, repeated-measures analysis showed a significant group-by-time interaction for T (p = 0.001), whereas 1-year changes in BMD and Z-scores did not differ between groups. Regression models showed that increased IGF-1 independently predicted improved total body BMD (p = 0.01). In conclusion, low-normal T in elite male endurance athletes was not associated with compromised bone health over 1 year and appeared largely reversible in the follow-up subset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.